Skip to main content
search

Preclinical

Sign up

Latest resources

Featured resource

Upcoming preclinical webinars

Latest preclinical blogs

Meet our experts at the following events

Conference

2026 ACCP Annual Meeting

September 27 - 29, 2026 – Bethesda N Marriott Hotel & Conf Ctr N Bethesda, MD
Conference

BioTechX Europe 2026

October 6 - 8, 2026
Conference

ISSX 27th North American Meeting

October 11 - 14, 2026 – San Francisco, CA

All preclinical resources

The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors

Certara Products - Simcyp, Drug Development, ICH M15, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), Webinar

5 Key Principles of Modern PK/PD in 2026

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, Guide

Development of a human PBMC TXG-MAPr as a mechanistic framework to interpret toxicodynamic variability across the human population

Certara Services, Poster

Characterization of human toxicodynamic variability using peripheral blood mononuclear cells from a large cohort of healthy volunteers

Certara Services, Poster

Integrating Endogenous Ligand Competition into a Mechanistic Whole-Body PBPK Model of Therapeutic Monoclonal Antibodies

Biologics, Certara Products - Simcyp, Certara Services, Drug Development, Model Informed Drug Development, Modeling and Simulation - PBPK, Therapeutic Specialties, Poster

63 Runs and No Convergence: When RsNLME Succeeded Where Other PK/PD Solutions Couldn’t

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, Blog, Case Study

Application of IO Simulator in Immuno-Oncology Combination Therapy: A Small Cell Lung Cancer Case Study

Biologics, Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation - QSP, Therapeutic Specialties, Poster

Mechanistic Modelling of CRS in T-cell Engagers – An Application for Blinatumomab

Certara Services, Clinical Pharmacology, Drug Safety, Model Informed Drug Development, Modeling and Simulation - QSP, Therapeutic Specialties, Poster

Machine Learning based drug renal clearance predictor development and application

AI, Certara Products - Simcyp, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Poster

Accelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimization

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Poster

Mechanistic QSP Modeling to Support KIT Inhibitor Dose Selection, Biomarker Strategy, and Clinical Development

Certara Services, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - QSP, Therapeutic Specialties, Poster

Building IND-Ready and Investor-Ready Development Programs

Certara Services, Clinical Pharmacology, Drug Development, Modeling and Simulation, New Approach Methodologies (NAMs), Webinar
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.